Legumes in bread baking: A hidden risk for an IgE-mediated inhalant allergy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.New legume flours in gluten-free baking pose inhalation allergy risks. A baker developed occupational asthma from chestnut pea flour, highlighting new sensitization concerns for workers.
Area Of Science
- Food Science
- Occupational Health
- Allergology
Background
- The rise of gluten-free products drives innovation in legume-based flours.
- Inhalation exposure to novel food dusts presents potential sensitization risks for food industry workers.
Observation
- A 29-year-old baker experienced work-related respiratory issues and incapacity.
- Sensitization was specifically linked to chestnut pea flour (Cicer arietinum), a legume flour used in gluten-free baking.
Findings
- Bronchial challenge testing confirmed significant allergic respiratory reactions to chestnut pea extract.
- Allergen component analysis identified IgE binding to storage proteins (2S albumin, vicilin), Bet v 1 homologues, and non-specific lipid transfer proteins in chestnut pea flour.
Implications
- This case highlights chestnut pea flour as a novel occupational allergen.
- Increased use of protein-rich legume flours necessitates awareness and management of new inhalation allergy risks in food processing environments.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Overview
We speak of an allergy when the immune system triggers a response against a benign foreign structure, like food, pollen or pet dander. These elicitors are called allergens. If the immune system of a hypersensitive individual was primed against a specific allergen, it will trigger allergic symptoms during every subsequent encounter of the allergen. Symptoms can be mild, such as hay fever, to severe, such as potentially fatal anaphylactic shock.
Sensitization Is the First Step of an...
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
5-Lipoxygenase Inhibitors: Some drugs in this class, like zileuton (Zyflo), inhibit an enzyme called 5-lipoxygenase. This enzyme is crucial in synthesizing...